平澤 欣吾先生の論文が掲載されました．
本論文は,当教室から初のSNADETに対する内視鏡治療のOverallの短期・長期成績をまとめたものです.久しくFirst authorはなかったのですが,ずっとこの論文がpublishされたら書こうと思っていたことがあります．
2020年,センター病院の内視鏡部から,10本の英語論文がpublishされました．これはセンター内視鏡部の先生たちの努力の賜以外,何者でもありません．
昨年,コロナ禍となり,我々医療従事者は非常な困難に直面しました．当内視鏡部も例外ではなく,通常診療と平行し,COVIDチームに駆り出された先生もいました。一方で,紹介患者の減少,検査枠・手術枠の削減に伴い,今までより臨床に費やす時間が減ったことは確かでした．そんな中,彼らはこの時間を有効活用すべく,学術的活動の邁進に機敏に方向転換し,この業績が積まれる結果に繋がったと思っています．
年間800件ほどのESDをこなし,さらに通常検査,外来,イレウスや消化管出血などの癌以外の急患の対応,DBEやEMSと,今までの日常は,僕たちに論文を書く体力を残すことを許容しないものでした．COVID19の怪我の功名というと不謹慎かもしれませんが,コロナ禍は,時間の余裕の大切さを痛感した局面でもあり,そこに時間を持て余すことなく対応出来た彼らには,本当に頭が下がります．
先生たちは、日々ひたむきに臨床を続け,自分たちの生きたデータを論文という形に残し,公開できるという喜びを知れたのではないでしょうか。これらの論文を読んだ人は,僕らのしてきた事,していく事を知ることができます．名刺代わりのIDになることが,今後分かってくるはずです．
あまり面と向かって言う機会がないのですが,先生たちに教えることは,実はもうほとんどないと思っています．あとは自分なりにmodifyしながら,次の世代が同じ楽しみを感じられるように,段々と上の学年になる準備をしていってください．
今回のScJGのIFは残念ながら高くありませんが,このことを伝える事が出来た点では十分だったと思っています．
これからも共に頑張っていきましょう．
平澤欣吾
This manuscript summarizes the short and long-term outcomes of overall of endoscopic treatment for SNADET for the first time from our division. I haven’t been a first author for a long time, but I had something to tell my colleague once it’s published.
In 2020, 10 English papers were published by the endoscopy division of the Center Hospital. This is nothing but the efforts of my colleague of this department.
Last year, we suffered from a Corona virus spread, and we medical professionals faced great difficulties. Our endoscopy division is no exception, and some doctors were forced to the COVID team in parallel with regular medical practice. On the other hand, as the number of referral patients decreased and the number of examination and treatment schedule decreased, the time spent on clinical practice was certainly reduced. In the meantime, they swiftly turned to the progress of academic activities in order to make effective use of this time, and I think that this achievement was accumulated.
We handle about 800 ESDs a year, and in addition to regular examinations, outpatients, dealing with emergency cases other than cancer such as ileus and gastrointestinal bleeding, DBE and EMS, our daily routine has not allowed us to leave energy to make a manuscript. It may be unscrupulous to say COVID19’s benefit, but Corona virus indicated also a phase where we realized the importance of having free time, and my colleague did not waste the time. Really, really impressed.
Perhaps the colleague knew the pleasure of continuing their clinical practice every day, making their raw data in the form of a manuscript, and publishing it. Those who read these papers will know what we have done and what we will do. It should be known in the future that it will be an ID instead of a business card.
I don’t have much opportunity to say it face-to-face, but you everyone don’t need to be taught anymore. After that, modify it in your own way and prepare for the higher grades so that the next generation can feel the same enjoyment.
Unfortunately, the impact factor of ScJG is not so high, but I think it was enough to be able to tell this message.
I look forward to working with you.
Kingo Hirasawa